Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-diethylaminoethyl-dextran methyl methacrylate copolymer non-viral vector-p53. (Q38451785)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-diethylaminoethyl-dextran methyl methacrylate copolymer non-viral vector-p53.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-diethylaminoethyl-dextran methyl methacrylate copolymer non-viral vector-p53. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

0 references

author name string

A Baliaka

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

P Zarogoulidis

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

K Domvri

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

W Hohenforst-Schmidt

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Sakkas

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

H Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

P Le Pivert

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

G Koliakos

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

E Koliakou

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

K Kouzi-Koliakos

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

K Tsakiridis

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Chioti

12

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

E Siotou

13

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Cheva

14

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

K Zarogoulidis

15

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

L Sakkas

16

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

28 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

158-167

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Genetics and biomarkers in personalisation of lung cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issues

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care--an observational analysis on non-small-cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Adenovirus-mediated interferon-γ gene therapy induced human pancreatic carcinoma Capan-2 cell apoptosis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Bronchoscopic intratumoral chemotherapy of lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Enhanced tumor treatment using biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Genetic protein TmSm(T34A) enhances sensitivity of chemotherapy to breast cancer cell lines as a synergistic drug to doxorubicin

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Do Liposomal Apoptotic Enhancers Increase Tumor Coagulation and End-Point Survival in Percutaneous Radiofrequency Ablation of Tumors in a Rat Tumor Model?

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Imaging of intratumoral inflammation during oncolytic virotherapy of tumors by 19F-magnetic resonance imaging (MRI)

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Tumor targeting and microenvironment-responsive nanoparticles for gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Toxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with Prodrugs

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Strategies to increase drug penetration in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Structure prediction and validation of an affibody engineered for cell-specific nucleic acid targeting

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Renal clearance of quantum dots

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Vascular permeability in a human tumour xenograft: molecular charge dependence

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Environment-responsive multifunctional liposomes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Multistage nanoparticle delivery system for deep penetration into tumor tissue

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [(11)C]docetaxel

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Local control of experimental malignant pancreatic tumors by treatment with a combination of chemotherapy and intratumoral 224radium-loaded wires releasing alpha-emitting atoms

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Improvement of antitumor effect of intratumoral injection of immature dendritic cells into irradiated tumor by cyclophosphamide in mouse colon cancer model

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Combination of cyclophosphamide, rituximab, and intratumoral CpG oligodeoxynucleotide successfully eradicates established B cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Ultrasonic enhancement of drug penetration in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Atrial natriuretic factor decreases renal dopamine turnover and catabolism without modifying its release

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Racial differences in end-stage renal disease rates in HIV infection versus diabetes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Case of pyomyositis due to Mycobacterium haemophilum in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Cre-lox-regulated conditional RNA interference from transgenes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Mechanism of introduction of exogenous genes into cultured cells using DEAE-dextran-MMA graft copolymer as non-viral gene carrier

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell culture

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

21 January 2018

Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it".

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled chemotherapy in lung cancer: safety concerns of nanocomplexes delivered

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/GT.2013.68

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38451785&oldid=2201725021"